Stock News

Amgen raises 2019 profit, sales view after buying Celgene psoriasis drug
Amgen Completes Acquisition Of Otezla® (apremilast)
Bristol-Myers Squibb completes $74 billion acquisition of Celgene
At Long Last, Bristol-Myers Buys Celgene
Celgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb
‘Hipster Antitrust’ Might End the Megamerger Party
[video]ServiceNow Jumps as Stock Is Added to the S&P 500, Replacing Celgene

As seen on...